Immune-mediated mechanisms influencing the efficacy of anticancer therapies

Immune-mediated mechanisms influencing the efficacy of anticancer therapies

Highlights • Anticancer therapies alter the composition, phenotype, and function of immune cells. • The immune system is a major regulator of the success of anticancer therapy. • Immunotherapy and immunomodulatory agents often synergize with conventional therapies. • Resistance mechanisms following...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in immunology 2015-04, Vol.36 (4), p.198-216
Hauptverfasser: Coffelt, Seth B, de Visser, Karin E
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Antineoplastic Agents - therapeutic use
Breast cancer
Chemotherapy
Humans
Immune system
Medical research
Neoplasms - drug therapy
Neoplasms - immunology
Neoplasms - pathology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 216
container_issue 4
container_start_page 198
container_title Trends in immunology
container_volume 36
creator Coffelt, Seth B
de Visser, Karin E
description Highlights • Anticancer therapies alter the composition, phenotype, and function of immune cells. • The immune system is a major regulator of the success of anticancer therapy. • Immunotherapy and immunomodulatory agents often synergize with conventional therapies. • Resistance mechanisms following immunotherapy and immunodulatory agents are not fully defined. • Targeting both cancer cells and immune cells may be the key to fight metastasis.
doi_str_mv 10.1016/j.it.2015.02.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1685752660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147149061500037X</els_id><sourcerecordid>3666541811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-cb397eca1d797105a89b5f51b2cde1aeadee9d8b4fc5b2494c1043b1a51cac1f3</originalsourceid><addsrcrecordid>eNpdkU1r3DAQhkVpaT6ae0_B0EsvdmZsy1pfAiW0TUigh7aQm5DlUaONLW8ku7D_vmM2TaEnDeiZ0atnhHiPUCBgc7Et_FyUgLKAsgBoXoljrBXmdbvB1y81NEfiJKUtMKiUeiuOSrmRqmnKY3F7M45LoHyk3puZ-mwk-2CCT2PKfHDDQsH68CubHygj57w1dp9NLjNh5jpYiutVNDtP6Z1448yQ6Oz5PBU_v3z-cXWd3337enP16S63nGXObVe1iqzBXrUKQZpN20knsSttT2jI9ERtv-lqZ2VX1m1tEeqqQyORX0dXnYqPh7m7OD0tlGY9-mRpGEygaUkaG_6dLJsGGP3wH7qdlhg4HVNKtsiQZAoOlI1TSpGc3kU_mrjXCHoVrbfaz3oVraHULJpbzp8HLx27e2n4a5aBywNAbOK3p6jt4AM7Gx5pT-lfDJ14ov6-7mpdFUoAqNR99QdAO48n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1675916605</pqid></control><display><type>article</type><title>Immune-mediated mechanisms influencing the efficacy of anticancer therapies</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Coffelt, Seth B ; de Visser, Karin E</creator><creatorcontrib>Coffelt, Seth B ; de Visser, Karin E</creatorcontrib><description>Highlights • Anticancer therapies alter the composition, phenotype, and function of immune cells. • The immune system is a major regulator of the success of anticancer therapy. • Immunotherapy and immunomodulatory agents often synergize with conventional therapies. • Resistance mechanisms following immunotherapy and immunodulatory agents are not fully defined. • Targeting both cancer cells and immune cells may be the key to fight metastasis.</description><identifier>ISSN: 1471-4906</identifier><identifier>EISSN: 1471-4981</identifier><identifier>DOI: 10.1016/j.it.2015.02.006</identifier><identifier>PMID: 25857662</identifier><language>eng</language><publisher>England: Elsevier Limited</publisher><subject>Allergy and Immunology ; Antineoplastic Agents - therapeutic use ; Breast cancer ; Chemotherapy ; Humans ; Immune system ; Medical research ; Neoplasms - drug therapy ; Neoplasms - immunology ; Neoplasms - pathology</subject><ispartof>Trends in immunology, 2015-04, Vol.36 (4), p.198-216</ispartof><rights>Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Apr 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-cb397eca1d797105a89b5f51b2cde1aeadee9d8b4fc5b2494c1043b1a51cac1f3</citedby><cites>FETCH-LOGICAL-c490t-cb397eca1d797105a89b5f51b2cde1aeadee9d8b4fc5b2494c1043b1a51cac1f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25857662$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Coffelt, Seth B</creatorcontrib><creatorcontrib>de Visser, Karin E</creatorcontrib><title>Immune-mediated mechanisms influencing the efficacy of anticancer therapies</title><title>Trends in immunology</title><addtitle>Trends Immunol</addtitle><description>Highlights • Anticancer therapies alter the composition, phenotype, and function of immune cells. • The immune system is a major regulator of the success of anticancer therapy. • Immunotherapy and immunomodulatory agents often synergize with conventional therapies. • Resistance mechanisms following immunotherapy and immunodulatory agents are not fully defined. • Targeting both cancer cells and immune cells may be the key to fight metastasis.</description><subject>Allergy and Immunology</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Breast cancer</subject><subject>Chemotherapy</subject><subject>Humans</subject><subject>Immune system</subject><subject>Medical research</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - pathology</subject><issn>1471-4906</issn><issn>1471-4981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1r3DAQhkVpaT6ae0_B0EsvdmZsy1pfAiW0TUigh7aQm5DlUaONLW8ku7D_vmM2TaEnDeiZ0atnhHiPUCBgc7Et_FyUgLKAsgBoXoljrBXmdbvB1y81NEfiJKUtMKiUeiuOSrmRqmnKY3F7M45LoHyk3puZ-mwk-2CCT2PKfHDDQsH68CubHygj57w1dp9NLjNh5jpYiutVNDtP6Z1448yQ6Oz5PBU_v3z-cXWd3337enP16S63nGXObVe1iqzBXrUKQZpN20knsSttT2jI9ERtv-lqZ2VX1m1tEeqqQyORX0dXnYqPh7m7OD0tlGY9-mRpGEygaUkaG_6dLJsGGP3wH7qdlhg4HVNKtsiQZAoOlI1TSpGc3kU_mrjXCHoVrbfaz3oVraHULJpbzp8HLx27e2n4a5aBywNAbOK3p6jt4AM7Gx5pT-lfDJ14ov6-7mpdFUoAqNR99QdAO48n</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Coffelt, Seth B</creator><creator>de Visser, Karin E</creator><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Immune-mediated mechanisms influencing the efficacy of anticancer therapies</title><author>Coffelt, Seth B ; de Visser, Karin E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-cb397eca1d797105a89b5f51b2cde1aeadee9d8b4fc5b2494c1043b1a51cac1f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Allergy and Immunology</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Breast cancer</topic><topic>Chemotherapy</topic><topic>Humans</topic><topic>Immune system</topic><topic>Medical research</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Coffelt, Seth B</creatorcontrib><creatorcontrib>de Visser, Karin E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Coffelt, Seth B</au><au>de Visser, Karin E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune-mediated mechanisms influencing the efficacy of anticancer therapies</atitle><jtitle>Trends in immunology</jtitle><addtitle>Trends Immunol</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>36</volume><issue>4</issue><spage>198</spage><epage>216</epage><pages>198-216</pages><issn>1471-4906</issn><eissn>1471-4981</eissn><abstract>Highlights • Anticancer therapies alter the composition, phenotype, and function of immune cells. • The immune system is a major regulator of the success of anticancer therapy. • Immunotherapy and immunomodulatory agents often synergize with conventional therapies. • Resistance mechanisms following immunotherapy and immunodulatory agents are not fully defined. • Targeting both cancer cells and immune cells may be the key to fight metastasis.</abstract><cop>England</cop><pub>Elsevier Limited</pub><pmid>25857662</pmid><doi>10.1016/j.it.2015.02.006</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-4906
ispartof Trends in immunology, 2015-04, Vol.36 (4), p.198-216
issn 1471-4906
1471-4981
language eng
recordid cdi_proquest_miscellaneous_1685752660
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Allergy and Immunology
Antineoplastic Agents - therapeutic use
Breast cancer
Chemotherapy
Humans
Immune system
Medical research
Neoplasms - drug therapy
Neoplasms - immunology
Neoplasms - pathology
title Immune-mediated mechanisms influencing the efficacy of anticancer therapies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A17%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune-mediated%20mechanisms%20influencing%20the%20efficacy%20of%20anticancer%20therapies&rft.jtitle=Trends%20in%20immunology&rft.au=Coffelt,%20Seth%20B&rft.date=2015-04-01&rft.volume=36&rft.issue=4&rft.spage=198&rft.epage=216&rft.pages=198-216&rft.issn=1471-4906&rft.eissn=1471-4981&rft_id=info:doi/10.1016/j.it.2015.02.006&rft_dat=%3Cproquest_cross%3E3666541811%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1675916605&rft_id=info:pmid/25857662&rft_els_id=1_s2_0_S147149061500037X&rfr_iscdi=true